public health policy Archives

Socioeconomic Genocide: The Silent Crisis of Healthcare Access How America is Killing Itself

Brian RogersJune 4, 20240379 views

The rising cost of prescription drugs in the United States disproportionately impacts Latino, Black, and immigrant communities, exacerbating existing health disparities. Economic barriers and chronic health conditions are prevalent among these groups, who often face significant obstacles to accessing necessary medications. This systemic issue, driven by corporate greed and governmental negligence, calls for urgent reforms to ensure universal healthcare access and address the socio-economic “genocide” affecting the less wealthy. By prioritizing affordability, access, and equity in healthcare, we can begin to mitigate these deep-rooted disparities.

Future at a Crossroads: The Escalating Cost of Living and Healthcare in America

Brian RogersJune 4, 20240143 views

As the trajectory of America’s economic and healthcare landscape points towards rising healthcare costs, corporate monopolization of essential services, and stagnant wage growth, the future appears daunting. A family of four may soon need to earn $200,000 annually by 2034 just to manage healthcare expenses. This article explores the systemic issues leading to these trends and their impact on daily living, emphasizing the need for significant policy changes to prevent an unsustainable future dominated by financial burdens and health disparities. The influence of big pharmaceutical companies, the monopolization of food production, and the socio-economic challenges faced by lower-income communities highlight the urgent need for reforms in healthcare and economic policies.

Health or Wealth: The High Cost of Living Under Big Pharma’s Rule

Brian RogersMay 31, 20240116 views

As healthcare and pharmaceutical costs skyrocket, a troubling pattern of control and coercion emerges. With drug prices reaching unprecedented heights, millions face a dire choice: surrender financial stability for life-saving medication or seek affordable treatments abroad, often navigating legal grey areas. This article explores how multinational corporations, with the complicity of a largely acquiescent legislative and executive branch, orchestrate economic and social enslavement by manipulating drug prices and market access through patent monopolies and restrictive trade agreements. The influence of Big Pharma, extensive lobbying efforts, and government collusion maintain high prices and limit competition, affecting global healthcare access and patient well-being.

Assessing the Impact of Regulatory Overreach: The FDA and U.S. Customs on Online Pharmacy Orders

Brian RogersMay 29, 20240113 views

The U.S. government, through agencies like the FDA and CBP, plays a crucial role in ensuring drug safety and regulating the entry of goods into the country. While these agencies aim to protect public health, their extensive regulatory reach often causes delays and increased costs, particularly impacting the availability of affordable medications through online pharmacies. This article examines how overregulation by the FDA and stringent enforcement by CBP can hinder access to essential medications, highlighting the need for streamlined processes and policy reforms to better serve the public interest.